IL-6 and HMGB1 levels in the serum and artery conduit tissues were significantly higher in patients with CAD, and a positive correlation between IL-6 and HMGB1 was observed in CAD patients, suggesting that IL-6 is the key effector cytokine for TLR4-driven VSMC migration. Here, IL6 is linked to coronary artery disorder.